FOR IMMEDIATE RELEASE
– January 12, 2015
January 14th, seven administrators from the Essure Problems Facebook Campaign, two of their attorneys, and Dr. Diana Zuckerman, President of The National Center for Health Research, will be meeting with several of their congressional leaders to discuss issues faced by thousands of women who have had complications due to Essure, a form of "non-surgical" permanent birth control.
The group will also be discussing the FDA’s role in the approval and monitoring of Essure, pre-market approval for Class III medical devices, and concerns with Medicaid's coverage of Essure. The goal of these meetings is to ultimately have Essure removed from the market for further study and to encourage change in the drug and device approval process by the FDA in order to better protect public health.
Meetings are scheduled with the following offices:
Senator Chuck Grassley (Iowa), Senator Roger Wicker (Mississippi) Senator Lamar Alexander (Tennessee) of the republican HELP committee, and members of the democratic HELP committee.
The group had reached out to the FDA to schedule a meeting and discuss their concerns, but it was ultimately denied by the FDA claiming too short of notice.
More meetings are still being coordinated.